However, development of Sivelestat was unsuccessful and discontinued in USA48, suggesting that specific inhibition of neutrophil elastase may not be beneficial to COPD and CF patients, which is also supported by the finding that depletion of neutrophil elastase in βENaC-Tg mice does not improve mucus obstructive phenotype49. This evidence concerns the gene ELANE and chronic obstructive pulmonary disease.